Group management raises sales target for 2025 to about 5 billion euros

29-Jan-2021

Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic. The Group closed the year with significant double-digit growth rates in sales revenue, ...

more

Positive development of the Lab Products & Services Division

21-Oct-2020

Sartorius closed the first nine months of 2020 with significant double-digit growth rates in sales revenue and earnings. “In the third quarter, we saw high demand for nearly our entire product range,” said Joachim Kreuzburg, CEO. “On top of overall strong organic growth, additional momentum was ...

more

Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group

17-Jul-2020

Based on the strong performance of the Bioprocess Solutions Division in the first half of 2020 as well as on high demand also expected to continue for the rest of the current fiscal year, Sartorius raised its full-year sales and earnings guidance for this division and thus for the entire Group. ...

more

Coronavirus pandemic so far with an overall neutral impact, but substantially different effects on the divisions

22-Apr-2020

Sartorius started off fiscal 2020 dynamically with significant double-digit growth in order intake, sales revenue and earnings. “We are very satisfied overall with our first-quarter results and confident about our business progress in the further course of the year,” commented CEO Dr. Joachim ...

more

25-Feb-2020

New brand promise, new logo, new colors – Sartorius looks different now. The company has revised its brand look. At the focus of this relaunch is Sartorius’ new brand promise that it summarizes in its new claim: Simplifying Progress. With its products and technologies, the company aims to ...

more

19-Feb-2020

Sartorius confirmed its preliminary figures upon publication of its 2019 Annual Report. Group sales revenue rose in constant currencies by 14.8% (reported: +16.7%) to 1,827.0 million euros. Growth was almost entirely organic as the acquisition of the cell culture media specialist Biological ...

more

Sartorius achieves significant increases in sales revenue and earnings again in 2019

29-Jan-2020

Sartorius has continued on its profitable growth track in fiscal 2019. The Group grew by double digits in sales revenue, order intake and earnings, recording gains in both divisions and across all regions. According to preliminary figures, Group sales revenue rose in constant currencies by 14.8% ...

more

Sartorius-AI-Lab (SAIL) is conducting research into the use of artificial intelligence in Sartorius platform solutions for the biopharmaceutical industry

02-Jan-2020

Sartorius and the German Research Center for Artificial Intelligence (DFKI) have established the Sartorius-AI-Lab (SAIL) research laboratory. On the campus of the DFKI in Kaiserslautern, the use of Artificial Intelligence (AI) in Sartorius product and platform solutions is being experimentally ...

more

21-Oct-2019

Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the year as ...

more

18-Apr-2019

Sartorius started off fiscal 2019 with substantial double-digit growth in order intake, sales revenue and earnings. Consolidated first-quarter sales revenue rose in constant currencies by 16.8% to 435.7 million reported: 19.4%); order intake increased 16.6% to 482.8 million euros (reported: ...

more